Hirose N, Arai Y, Kawamura M, Shigematu H
Department of Geriatric Medicine, School of Medicine, Keio University, Tokyo, Japan.
Keio J Med. 1996 Jun;45(2):90-4. doi: 10.2302/kjm.45.90.
Oxidized-low density lipoprotein (ox-LDL) exhibits various atherogenic properties, such as the formation of foam cells, the recruitment of macrophages into arteries, the promotion of cell growth, the formation of thrombi, and the development of vasoconstriction. Antioxidants inhibit atherosclerosis in cholesterol-fed animals by preventing the recruitment of macrophages into the arteries suggesting that oxidation is important for such recruitment of macrophages, and that it is responsible for early development of atherosclerosis. Calcification and an increase in extracellular matrix (ECM) are frequently observed in advanced atherosclerosis. These processes are active and regulated, not passive and degenerative, and do not appear to be controlled by ox-LDL. The control of calcifications and ECM increase will provide new directions in the treatment of atherosclerosis especially in the advanced stages. Future treatment should include strategies to inhibit the calcification and the increase in ECM.
氧化型低密度脂蛋白(ox-LDL)具有多种致动脉粥样硬化特性,如泡沫细胞的形成、巨噬细胞向动脉内的募集、细胞生长的促进、血栓的形成以及血管收缩的发展。抗氧化剂通过阻止巨噬细胞向动脉内募集,从而抑制喂食胆固醇动物的动脉粥样硬化,这表明氧化对于巨噬细胞的这种募集很重要,并且它是动脉粥样硬化早期发展的原因。在晚期动脉粥样硬化中经常观察到钙化和细胞外基质(ECM)增加。这些过程是活跃且受调控的,并非被动和退行性的,并且似乎不受ox-LDL控制。钙化和ECM增加的控制将为动脉粥样硬化的治疗提供新方向,尤其是在晚期阶段。未来的治疗应包括抑制钙化和ECM增加的策略。